Spike-antibody waning after second dose of BNT162b2 or ChAdOx1
Vaccines based on the spike glycoprotein of SARS-CoV-2 are being rolled out globally to
control transmission and limit morbidity and mortality due to COVID-19. Current evidence …
control transmission and limit morbidity and mortality due to COVID-19. Current evidence …
[HTML][HTML] Prevalence and characteristics of persistent symptoms in children during the COVID-19 pandemic: evidence from a household cohort study in England and …
F Miller, V Nguyen, AMD Navaratnam… - The Pediatric …, 2022 - journals.lww.com
This work was supported by the Medical Research Council [grant numbers MC_PC19070
and MR/V028375/1, and MR/N013867/1 to Miss Miller] and the Wellcome Trust [grant …
and MR/V028375/1, and MR/N013867/1 to Miss Miller] and the Wellcome Trust [grant …
[HTML][HTML] Spike-antibody responses to COVID-19 vaccination by demographic and clinical factors in a prospective community cohort study
M Shrotri, E Fragaszy, V Nguyen… - Nature …, 2022 - nature.com
Vaccination constitutes the best long-term solution against Coronavirus Disease-2019;
however, vaccine-derived immunity may not protect all groups equally, and the durability of …
however, vaccine-derived immunity may not protect all groups equally, and the durability of …
[HTML][HTML] Nucleocapsid and spike antibody responses following virologically confirmed SARS-CoV-2 infection: an observational analysis in the Virus Watch community …
AMD Navaratnam, M Shrotri, V Nguyen… - International Journal of …, 2022 - Elsevier
Objectives Seroprevalence studies can provide a measure of SARS-CoV-2 cumulative
incidence, but a better understanding of spike and nucleocapsid (anti-N) antibody dynamics …
incidence, but a better understanding of spike and nucleocapsid (anti-N) antibody dynamics …
[HTML][HTML] SARS-CoV-2 antibodies and breakthrough infections in the Virus Watch cohort
A range of studies globally demonstrate that the effectiveness of SARS-CoV-2 vaccines
wane over time, but the total effect of anti-S antibody levels on risk of SARS-CoV-2 infection …
wane over time, but the total effect of anti-S antibody levels on risk of SARS-CoV-2 infection …
Waning of SARS-CoV-2 antibodies targeting the Spike protein in individuals post second dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and risk of …
Background SARS-CoV-2 vaccines stimulate production of antibodies targeting the spike
protein (anti-S). The level of antibodies following vaccination and trajectories of waning may …
protein (anti-S). The level of antibodies following vaccination and trajectories of waning may …
Occupation, work-related contact and SARS-CoV-2 anti-nucleocapsid serological status: findings from the Virus Watch prospective cohort study
Objectives Risk of SARS-CoV-2 infection varies across occupations; however, investigation
into factors underlying differential risk is limited. We aimed to estimate the total effect of …
into factors underlying differential risk is limited. We aimed to estimate the total effect of …
[HTML][HTML] Differential risk of SARS-CoV-2 infection by occupation: evidence from the virus Watch prospective cohort study in England and Wales
Background Workers across different occupations vary in their risk of SARS-CoV-2 infection,
but the direct contribution of occupation to this relationship is unclear. This study aimed to …
but the direct contribution of occupation to this relationship is unclear. This study aimed to …
[HTML][HTML] Workplace contact patterns in England during the COVID-19 pandemic: Analysis of the Virus Watch prospective cohort study
Background Workplaces are an important potential source of SARS-CoV-2 exposure;
however, investigation into workplace contact patterns is lacking. This study aimed to …
however, investigation into workplace contact patterns is lacking. This study aimed to …
[HTML][HTML] Trends, patterns and psychological influences on COVID-19 vaccination intention: Findings from a large prospective community cohort study in England and …
Background Vaccination intention is key to the success of any vaccination programme,
alongside vaccine availability and access. Public intention to take a COVID-19 vaccine is …
alongside vaccine availability and access. Public intention to take a COVID-19 vaccine is …